LMAT - Admedus divests its CardioCel And VascuCel patch business October, 14 2019 09:47 AM LeMaitre Vascular Inc. Admedus to sell its CardioCel and VascuCel patch business to LeMaitre Vascular (LMAT +6%) for up to .2M, including .8M upfront.More news on: LeMaitre Vascular, Inc., Healthcare stocks news, Merger & acquisition news, Read more ...